No Detail Found!

Repurposing of antiviral drugs for Covid-19 therapy

Author(s)
Hussain Mustatab Wahedi Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan
Deeba Amraiz Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan
Abstract
Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome-associated coronavirus 2 (SARSCoV-2) is one of the biggest health challenges across the globe ever since its eruption in late 2019. Novelty, contagiousness, and lethality of the virus demand the expedited production of potential therapeutic agents and strategies against it. Since no COVID-19 specific drug is available yet, it persists a crucial challenge to determine what therapeutic strategies should be adopted for the treatment of coronavirus patients. Until there is any specific drug for COVID-19, repurposing of the existing FDA-approved drugs is the most suitable approach to treat the severely ill patients of COVID-19. This review will summarize the existing antiviral drugs being repurposed and probed for their potential as effective anti-COVID-19 drugs all over the world.
Publication Details
Page(s) 22-31
Published Journal: Life and Science, Volume: 1, Issue: SI, Year: 2020

Request the full text from PASTIC

Keywords
Coronavirus, Antiviral Drugs, Drug Repurposing, Drug repositioning
0

Citations

0

Downloads

41

Views